Northbrook, IL 60062 -- (SBWire) -- 10/27/2023 --Bone Cement & Glue Market by Bone Cement (PMMA, Calcium Phosphate), Bone Glue (Natural, Synthetic), Loading (Antibiotic Loaded), Application (Arthroplasty, Kyphoplasty, Vertebroplasty), End User (Hospitals, ASCS, Clinics) - Global Forecast to 2028", is projected to reach USD 2,248 million by 2028 from USD 1,644 million in 2023, at a CAGR of 6.5% during the forecast period.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131540876
Browse in-depth TOC on "Bone Cement & Glue Market"
167 - Tables
32 - Figures
188 - Pages
Key Market Players:
The significant players in the Bone cement & glue market are Stryker (US), Zimmer Biomet (US), DePuy Synthes (a subsidiary of Johnson & Johnson - US), Enovis (US), Heraeus Holding (Germany), Medtronic (Ireland)
Bone Cement & Glue Market Dynamics:
Drivers:
Growing incidences of sports injuries
Restraints:
High costs and extensive clinical data requirements for launching new bone cements
Opportunities:
Rising awareness and demand for minimally invasive procedures
Challenges:
Product-related complications
France in European Bone cement & glue market to witness the highest shares during the forecast period.
The Europe Bone cement & glue market is segmented into Germany, France, the UK, and the Rest of Europe. France is projected to occupy the highest share during the forecast period. The major factors contributing to the growth of this market are the high prevalence of Orthopedic Conditions, the growing geriatric population, In addition, France has a well-developed healthcare system with access to advanced medical technologies and treatments. This infrastructure supports the adoption of bone cement and glue products in various orthopedic and dental procedures. Likewsie, France has a skilled workforce of healthcare professionals, including orthopedic surgeons, who are adept at using bone cement and glue products in surgical procedures.
Hospitals, & Ambulatory Surgical Centers in End user' Bone cement & glue market to witness the highest growth rate during the forecast period.
Based on the end user, the Bone cement & glue market is segmented into Hospitals, & Ambulatory Surgical Centers, and Clinics/Physician offices. The Hospitals, & Ambulatory Surgical Centers registered the highest CAGR, increasing orthopedic Surgical Procedures, Hospitals and ASCs are key providers of joint replacement surgeries, such as total hip arthroplasty (THA) and total knee arthroplasty (TKA), moreover Hospitals and ASCs cater to patients of all ages, but the aging population is more likely to require orthopedic surgeries that involve bone cement and glue. As the global population ages, the demand for joint replacement surgeries and other orthopedic procedures is increasing, benefiting the bone cement and glue market.
China dominates the Asia Pacific Bone cement & glue market.
The APAC amniotic products market is segmented into Japan, China, India, and Rest of Apac. In 2022, China accounted for the largest share of the Asian Bone cement & glue market. The large share of China can be attributed to the economic growth in the country, rising incidence of orthopedic cases, significantly high cases of road accidents, increasing disposable income of the middle-class population, growth in the geriatric population, and favourable government support.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=131540876
Recent Developments:
- In 2021, The company Smith & Nephew (UK) acquired the Extremity Orthopedics business of Integra LifeSciences to expand its shoulder, upper, and lower extremities product portfolio.
- In 2021, Zimmer Biomet (US) Completed the spinoff of spine and dental businesses into a new public company, ZimVie Inc. ("ZimVie"). The transaction was intended to benefit its stockholders by enhancing the focus of both Zimmer Biomet and ZimVie to meet the needs of patients and customers.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=131540876
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Exploring the Bone Cement & Glue Market: Benefits, Growth Trends, Demands, and Applications - Forecast Through 2028
In 2021, The company Smith & Nephew (UK) acquired the Extremity Orthopedics business of Integra LifeSciences to expand its shoulder, upper, and lower extremities product portfolio.